ahlam1399
07-22-2015, 01:06 PM
UPDATE 1-AstraZeneca suffers setback as drug fails in eye cancer
* 2020 consensus sales forecast for selumetinib $305 mln (Adds sales forecast, analyst comment, disease details)http://feeds.feedburner.com/~ff/reuters/hotStocksNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=keffdp7eHEA:7mDMCgdezIo:yIl2AUoC8z A) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=keffdp7eHEA:7mDMCgdezIo:F7zBnMyn0L o (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=keffdp7eHEA:7mDMCgdezIo:F7zBnMyn0L o) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=keffdp7eHEA:7mDMCgdezIo:V_sGLiPBpW U (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=keffdp7eHEA:7mDMCgdezIo:V_sGLiPBpW U)
http://feeds.feedburner.com/~r/reuters/hotStocksNews/~4/keffdp7eHEA
* 2020 consensus sales forecast for selumetinib $305 mln (Adds sales forecast, analyst comment, disease details)http://feeds.feedburner.com/~ff/reuters/hotStocksNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=keffdp7eHEA:7mDMCgdezIo:yIl2AUoC8z A) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=keffdp7eHEA:7mDMCgdezIo:F7zBnMyn0L o (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=keffdp7eHEA:7mDMCgdezIo:F7zBnMyn0L o) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=keffdp7eHEA:7mDMCgdezIo:V_sGLiPBpW U (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=keffdp7eHEA:7mDMCgdezIo:V_sGLiPBpW U)
http://feeds.feedburner.com/~r/reuters/hotStocksNews/~4/keffdp7eHEA